Skip to content

A Lifecourse Map of Diseases in China

A Lifecourse Map of Common Diseases and Rare Diseases in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05612230
Enrollment
40000000
Registered
2022-11-10
Start date
2022-08-01
Completion date
2024-07-31
Last updated
2022-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Diseases, Rare Diseases

Brief summary

The purpose of this study is to form a chronological map of common diseases and rare diseases in Chinese population by determining the prevalence of different diseases in each age group.

Detailed description

Studying the distribution of various diseases in specific populations can help explore the causes of diseases, elucidate the distribution patterns, and develop preventive and control measures. Based on an overall assessment of prevalence, the combination of relevant results with age at diagnosis for multiple diseases is important for further understanding of the distribution of diseases at the population level. Therefore, this study aims to form a chronological map of common diseases and rare diseases in Chinese population by determining the prevalence of different diseases in each age group, thus providing a reference for more effective prevention, diagnosis and treatment of diseases.

Interventions

Data analysis is based on a single database from the National Health Medical Data (North Center).

Sponsors

National Health Medical Data (North Center)
CollaboratorUNKNOWN
Shandong University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. All inpatients within the period of January 1, 2017 to December 31, 2021. 2. Patients with discharge diagnosis. 3. Patients with accurate gender and age records.

Exclusion criteria

1. Morbidity and mortality due to external causes, i.e. injuries, poisonings and other adverse events due to external environment and accidents. 2. Pregnancy-related conditions. 3. Symptoms, signs, abnormal clinical and laboratory findings. 4. Traditional Chinese Medicine diagnosis records. 5. Patients with incorrect or missing disease codes.

Design outcomes

Primary

MeasureTime frameDescription
age-specific prevalence ratebetween January 1, 2017 and December 31, 2021Age-specific prevalence rate stratified by sex were calculated by dividing the number of incident cases with a current disease by the total number of people in the study population during that time period.
sex-specific prevalence ratebetween January 1, 2017 and December 31, 2021Sex-specific prevalence rate stratified by age for 10-year bands were calculated by dividing the number of incident cases with a current disease by the total number of people in the study population during that time period.

Secondary

MeasureTime frameDescription
total cost of hospitalizationbetween January 1, 2017 and December 31, 2021Total cost of hospitalization and deductibles for the total population and for each age group of diseases are described by mean (SD) values.

Countries

China

Contacts

Primary ContactWei Zhao, Ph.D
zhao4wei2@hotmail.com86053188383308

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026